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Abstract
Introduction Early nutrition is recommended for patients with
sepsis, but data are conflicting regarding the optimum route of
delivery. Enteral nutrition (EN), compared with parenteral
nutrition (PN), results in poorer achievement of nutritional goals
but may be associated with fewer infections. Mechanisms
underlying differential effects of the feeding route on patient
outcomes are not understood, but probably involve the immune
system and the anabolic response to nutrients. We studied the
effect of nutrition and the route of delivery of nutrition on
cytokine profiles, the growth hormone–insulin-like growth
factor-1 (IGF-I) axis and a potential mechanism for immune and
anabolic system interaction, the suppressors of cytokine
signaling (SOCS), in rodents with and without sepsis.
Methods Male Sprague–Dawley rats were randomized to
laparotomy (Sham) or to cecal ligation and puncture (CLP), with
postoperative saline infusion (Starve), with EN or with PN for 72
hours. Serum levels of IL-6 and IL-10 were measured by
immunoassay, and hepatic expressions of cytokine-inducible
SH2-containing protein, SOCS-2, SOCS-3, IGF-I and the
growth hormone receptor (GHR) were measured by real-time
quantitative PCR.
Results IL-6 was detectable in all groups, but was only present
in all animals receiving CLP-PN. IL-10 was detectable in all but
one CLP-PN rat, one CLP-EN rat, approximately 50% of the
CLP-Starve rats and no sham-operated rats. Cytokine-inducible
SH2-containing protein mRNA was increased in the CLP-EN
group compared with the Sham-EN group and the other CLP
groups (P < 0.05). SOCS-2 mRNA was decreased in CLP-PN
rats compared with Sham-PN rats (P = 0.07). SOCS-3 mRNA
was increased with CLP compared with sham operation (P <
0.03). IGF-I mRNA (P < 0.05) and GHR mRNA (P < 0.03) were
greater in the fed CLP animals and in the Sham-PN group
compared with the starved rats.
Conclusion In established sepsis, nutrition and the route of
administration of nutrition influences the circulating cytokine
patterns and expression of mRNA of SOCS proteins, GHR and
IGF-I. The choice of the administration route of nutrition may
influence cellular mechanisms that govern the response to
hormones and mediators, which further influence the response
to nutrients. These findings may be important in the design and
analysis of clinical trials of nutritional interventions in sepsis in
man.
Introduction
Early initiation of nutritional support is now considered a stand-
ard of care for patients with critical illness in intensive care
units. Consensus guidelines recommend the use of enteral
nutrition (EN) over parenteral nutrition (PN) unless there is a
contraindication to using the gut [1]. Recent studies, however,
have shown that it is commonly difficult to achieve adequate
nutrition via the enteral route in critically ill patients [2,3]. Meta-
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analyses of trials comparing EN with PN in critically ill patients
have been published [4,5] but interpretation of the results is
made difficult by the small sample sizes of individual trials and
significant problems with the trial design [5]. The question
therefore remains of what is the optimum nutrition regimen for
critically ill patients and, in the absence of good quality clinical
trial data, clinicians may need to turn to basic science investi-
gations to aid decision-making.
The mechanism by which outcome in critically ill patients might
be influenced by the early initiation of nutritional support and
the route of delivery of the nutrition is not well understood.
Hypotheses favoring EN include prevention of bacterial over-
growth in the stomach or bacterial translocation from the gas-
trointestinal tract, whereas anabolic effects of the delivered
nutrients might favor PN. Any acute effects on patient out-
comes, however, are most likely to be mediated through
changes in the activity of the immune system. In this regard,
the effect of sepsis and the influence of nutrition on tissue pro-
tein metabolism and on the functioning of the growth hormone
(GH)–insulin-like growth factor-I (IGF-I) axis is of particular
interest. While a derangement in the functioning of this axis,
termed 'GH resistance', has been implicated as important in
the pathogenesis of muscle protein catabolism in critical ill-
ness [6], it is now recognized that the activity of anabolic pep-
tides in the GH family and the activity of cytokines are linked
through a common cellular receptor [7]. This provides a mech-
anism whereby changes in the activity of this axis may influ-
ence cytokine release, and vice versa.
GH resistance in critical illness is characterized by a rapid and
sustained decrease in circulating and tissue concentrations of
IGF-I despite elevated circulating levels of GH, the main effec-
tor of IGF-I secretion [8]. The mechanism by which GH resist-
ance occurs is not fully understood, but changes both in
nutrient availability and in cytokine activation are implicated.
Circulating levels of IGF-I and of the insulin-like growth factor
binding protein-I (IGFBP-I) are exquisitely sensitive to provi-
sion of nutrients, the former being increased and the latter
being suppressed by food intake [9]. Hepatic IGFBP-I synthe-
sis is stimulated by the cytokines IL-1, IL-6 and TNFα [10], and
circulating IGFBP-I levels are frequently elevated in critically ill
patients on intensive care unit admission [11].
Recent work has focused on the potential for a direct interac-
tion between the GH–IGF-I axis and the immune system via
the common cellular receptor. The suppressors of cytokine
signaling (SOCS) proteins are inhibitors of cytokine and GH
signaling via the janus kinase and signal transducer and acti-
vator pathway, which appear to inhibit cytokine and GH sign-
aling as part of a classical negative feedback loop [12].
Increased hepatic mRNA of SOCS proteins has been shown
to occur transiently in abdominal sepsis and to be temporally
associated with the development of GH resistance [13]. In a
study employing a rodent model of sepsis – cecal ligation and
puncture (CLP) – a relationship was observed between the
induction of SOCS and both the presence of sepsis and the
administration of PN [14]. Administration of 16 hours of PN
was associated with induction of the expression of hepatic
mRNA of the SOCS cytokine-inducible SH2-containing pro-
tein (CIS). This finding suggested a mechanism by which nutri-
tion might modulate both cytokine profiles and the response to
anabolic hormones such as GH in sepsis; however, it is not
clear whether this observation represents a consequence of
an effect of PN, via an effect on cytokine patterns for example,
or a consequence of the provision of nutrients per se.
We have compared isocaloric and isonitrogenous PN with EN
commenced immediately following CLP in rats and continued
for 72 hours [15]. We found that PN alone was able to
increase hepatic protein synthesis and resulted in improved
net skeletal muscle protein metabolism compared with EN.
Serum IGF-I was lower in CLP animals administered PN or EN
when compared with the matched sham-operated groups.
After CLP, PN but not EN was associated with increased IGF-I
compared with the levels measured in starved animals. IGFBP-
I was increased in CLP animals compared with sham and
increased in starved animals compared with those receiving
nutrition. PN was associated with the lowest serum IGFBP-I
levels in both the CLP and sham-operated groups. We hypoth-
esized that, in sepsis, administration of nutrition and the route
of its administration influence hepatic cellular responses to
GH by modulation of SOCS proteins, either directly or via dif-
ferential activation of cytokines. We therefore measured the
serum concentrations of a pleiotropic cytokine (IL-6) and an
anti-inflammatory (IL-10) cytokine and the expression of mRNA
of SOCS proteins, of IGF-I and of the growth hormone recep-
tor (GHR) in hepatic tissue from these animals. These results
are reported in the present manuscript.
Materials and methods
Experimental design
The Animal Care and Ethics Committee of Royal North Shore
Hospital and the University of Technology, Sydney, Australia
approved the protocol. Sixty-seven male Sprague–Dawley rats
(body weight 180–220g) were received from Gore Hill Animal
Research Laboratories (University of Technology, Sydney,
Australia) and were housed individually in metabolic cages in
a temperature-controlled (23–25°C) and light-controlled (12-
hour light/12-hour dark) environment. The animals were initially
given access to rat chow and water ad libitum for a period of
7 days. Following this acclimatization period, the animals were
anesthetized by intraperitoneal injection of ketamine (50 mg/
kg body weight) (Ketalar; Parke Davis, Sydney, NSW, Aus-
tralia) and sodium pentobarbitone (30 mg/kg body weight)
(Nembutal; Rhone Merieux, Parramatta, NSW, Australia) and
had a catheter aseptically implanted into the right internal jug-
ular vein as described previously [16]. A midline laparotomy
was performed and a further catheter was inserted through the
anterior wall of the stomach, sutured to the stomach wall andAvailable online http://ccforum.com/content/11/4/R79
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exteriorized through the antero-lateral abdominal wall. This
catheter was then subcutaneously tunneled to lie alongside
the intravenous line.
The animals were randomized into six groups. At laparotomy,
three groups underwent CLP and postoperatively received PN
(CLP-PN group, n = 12), EN (CLP-EN group, n = 13) or a con-
tinuous infusion (0.5 ml/hour) of isotonic saline (starvation;
CLP-Starve group, n = 16). The remaining three groups of ani-
mals were subjected to laparotomy only (sham operation;
Sham group) and received the same feeding regimen as the
CLP animals (Sham-PN group, n = 8; Sham-EN group, n = 6;
and Sham-Starve group, n = 12). The PN and EN solutions
were identical and provided the daily requirement of energy
(1.40 MJ/kg body weight/day), amino acid nitrogen (1.3 g N/
kg body weight/day), essential fatty acids, vitamins, minerals
and trace elements in a volume equivalent to 230 ml/kg body
weight/day [16].
Following anesthesia and surgery, the animals were given 2.5
ml/100 g body weight of 0.9% sodium chloride containing 0.3
mg/kg buprenorphine intraperitoneally to provide fluid resusci-
tation and analgesia. The rats were then returned to their
cages. Oral food (standard rat chow) was removed on the day
of operation, but free access to water was continued. Further
doses of intraperitoneal fluid and analgesia were administered
24 and 48 hours following operation.
Cecal ligation and puncture procedure
Following placement of the stomach catheter, in animals rand-
omized to CLP the cecum was identified and tightly ligated at
its base with great care taken to ensure that continuity of the
bowel was preserved. A 23 G needle was used to puncture
the cecum in a single pass through the anterior and posterior
walls. The cecum was then gently squeezed to extrude fecal
matter. Only one person performed the CLP throughout the
entire study to ensure consistency. In sham animals, the
cecum was lifted out of the peritoneal cavity, gently squeezed
and then returned.
Procedures at study endpoint
Animals were studied 72 hours following CLP or sham opera-
tions. Only animals surviving to this time point could be stud-
ied. One animal from the Sham-Starve group died prior to the
study endpoint from an unknown cause; all other sham-oper-
ated animals survived. Eight CLP-PN rats, five CLP-EN rats
and 15 CLP-Starve animals survived. The surviving animals
were sacrificed at this time by intravenous injection of a lethal
dose of sodium pentabarbitone. Full details of procedures at
the time of sacrifice have been previously published [15].
Immediately following sacrifice blood was collected, via car-
diac puncture, for measurement of serum levels of IL-6 and IL-
10. The abdomen was then opened and the liver was rapidly
removed, weighed and flash frozen in liquid nitrogen. The liver
was stored at -70°C for subsequent analysis for the expres-
sion of mRNA of CIS, SOCS-2, SOCS-3, IGF-I and the GHR.
Rat IL-6 and IL-10 immunoassays
Serum levels of IL-6 and IL-10 were measured using a Quan-
tikine® Immunoassay system (R&D Systems, Minneapolis, MN,
USA) as per the manufacturer's instructions. Briefly, following
the addition of 50 μl assay diluent, 50 μl serum (1:1 dilution for
IL-6; undiluted for IL-10) was added to the plate and the mix-
ture was incubated for 2 hours at room temperature. The plate
was washed five times and then 100 μl conjugate (anti-rat IL-
6–horseradish peroxidase; anti-rat IL-10–horseradish peroxi-
das) was then added and incubated for 2 hours at room tem-
perature. The plate was then washed a further five times and
100 μl substrate solution (equal volumes of hydrogen peroxide
and the chromagen tetramethylbenzidine) was added and
incubated for a further 30 minutes at room temperature.
Finally, 100 μl stop solution (HCl) was added and the absorb-
ance was measured at 450 nm. The minimum limit of detection
of the IL-6 assay is 14 pg/ml, and that for IL-10 is <10 pg/ml.
Measurement of mRNA for SOCS proteins, IGF-I and 
GHR
The specific primers used for real-time quantitative RT-PCR
for targeting mRNA expression values were designed with the
assistance of the PRIMER 3 software [17]. The primers were:
SOCS2, 5'-GCG TGA GCT CAG TCA AAC AG-3' and 5'-
CCC GGC TGA TGT CTT AAC AG-3'; SOCS3, 5'-CCT CAA
GAC CTT CAG CTC CA-3' and 5'-CGG TTA CGG CAC
TCC AGT AG-3'; CIS, 5'-GCT TGT CGA GAC CTC GAA TC-
3' and 5'-CAG GAT CTG GGC TGT CAC TC-3'; IGF-1, 5'-
TCA GTT CGT GTG TGG ACC AAG-3' and 5'-TCA CAG
CTC CGG AAG CAA C-3'; GHR, 5'-ATC TTT GGC GGG
TGT TCT TA-3' and 5'-TAG CTG GTG TAG CCC CAC TT-3'.
Two micrograms of total RNA treated with DNase I (Sigma, St
Louis, MO, USA) was used for the RT reaction, with the cDNA
stored at -20°C until use. Real-time quantitative RT-PCR was
performed using the iCycler iQ system (BioRad, Hercules, CA,
USA) employing SYBR Green I fluorescence (Sigma) accord-
ing to the manufacturer's instructions. Amplification of all
mRNAs was performed in duplicate in a PCR 96-well reaction
plate (BioRad). The following experimental run protocol was
used. cDNA was denatured at 95°C for 5 minutes to activate
the Hot-start Taq  DNA polymerase. The amplification and
quantification program was repeated 40 times (95°C for 20 s,
60°C for 1 min, 72°C for 30 s, with a single fluorescence
measurement).
After the PCR a melting curve was constructed by increasing
the temperature from 55°C to 95°C at a heating rate of 0.5°C/
10 seconds with continuous fluorescence measurements. The
PCR efficiency (E) and the cycle threshold (CT) for each sam-
ple was determined using iCycle software (BioRad). The
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was defined as the mean normalized gene expression (MNE)
difference in target gene expression relative to the 'house-
keeping gene' 18S rRNA using the following equation [18]:
MNE = [(Eref)CTref,mean]/[(Etarget)CTtarget,mean].
Statistical analysis
Statistical evaluation of data was performed using analysis of
variance with Tukey's test post hoc by Instat GraphPad ver-
sion 5.02 (GraphPad Software, Inc., San Diego, CA, USA).
Cytokine measurements below the lower limit of detection of
the assays were allocated an arbitrary value of 1 ng/ml to per-
mit intergroup statistical analysis. Differences detected
between groups were considered significant at P < 0.05.
Results
Serum levels of IL-6 and IL-10
Circulating IL-6 was measurable in animals from each of the
experimental groups, but only the group receiving PN follow-
ing CLP had measurable levels in all animals. In each of the
other groups a number of animals had levels below the lower
limit of detection of the assay (Figure 1). Animals with unde-
tectable levels of IL-6 were more frequent in the Starve groups
than in those receiving nutrition. The only differences for IL-6
that attained statistical significance were in animals receiving
PN following CLP, where IL-6 levels were greater compared
both with starvation following CLP and with PN following the
sham operation (Figure 2).
Levels of IL-10 were below the lower limit of detection of the
assay in all animals in the sham-operated groups and in all but
one of the animals receiving EN following CLP, whereas all but
one of the CLP-PN animals had measurable levels of circulat-
ing IL-10 (Figure 1). The levels of IL-10 measured in the CLP-
PN group were significantly greater than those measured in all
sham-operated groups (Figure 2).
Hepatic expression of mRNA for CIS, SOCS-2, SOCS-3, 
IGF-I and GHR
The MNE of mRNA for CIS was significantly increased in CLP-
EN rats compared with Sham-EN animals and compared with
animals from the other CLP groups (Figure 3). The MNE of
mRNA for SOCS-2 was decreased in CLP-PN animals com-
pared with Sham-PN animals, but was otherwise not different
between the groups. The SOCS-3 mRNA MNE was signifi-
cantly increased in all CLP animals when compared with sham
animals from the matched feeding groups. In addition, the
MNE was greater in CLP-PN animals compared with CLP-EN
animals (P = 0.056). In the sham-operated animals, the MNE
of mRNA for SOCS-3 was significantly lower in animals
receiving PN compared with starvation animals.
The MNE of mRNA for IGF-I was in general increased by feed-
ing compared with starvation, significant differences being
observed between both the CLP-PN group and the CLP-EN
group and CLP-Starve group, and between Sham-PN rats and
Sham-Starve rats (Figure 4).
The MNE of mRNA for the GHR was increased by feeding
compared with starvation for both CLP and sham-operated
animals, but there was no difference comparing PN with EN in
either of the surgical groups (Figure 4).
Discussion
In this study we have shown that the use of EN compared with
PN in rats with abdominal sepsis can influence serum levels of
IL-6 and IL-10. The route of administration of nutrition also
influenced the expression of mRNA of SOCS proteins in the
liver. CIS was increased in sepsis by EN and SOCS-2 in sham
operation by PN, whereas SOCS-3 was increased with PN
after CLP and decreased with PN after sham operation. Nutri-
tion increased the expression of mRNA of both IGF-I and the
GHR, while these were not affected by sepsis. These results
support a potential effect of nutrition and the route of adminis-
tration of nutrition on the activity of the GH–IGF-I axis that may
be mediated by cytokine production and by alterations in intra-
cellular signaling mechanisms involving the SOCS proteins.
A number of studies in both animals and man show differences
in immune system function in association with the administra-
tion of PN compared with EN [19-22]. These differences are
considered to be driven principally by changes at the level of
the mucosa of the gastrointestinal tract. In mice, the presence
or absence of nutrients within the gut lumen has a major influ-
ence on the size and function of the gut mucosal immune sys-
tem. PN is associated with a rapid fall in lymphocyte cell
counts and a change in cell profiles in gut-associated lym-
phoid tissue; this profile change is related to decreased levels
of the Th2 cytokines IL-4 and IL-10 [23]. These changes
appear to be important since, compared with chow feed, PN
in animals is associated with enhanced transport of endotoxin
Figure 1
Serum levels of IL-6 and IL-10 Serum levels of IL-6 and IL-10. Percentage of animals in each of the 
experimental groups that had serum levels of IL-6 and IL-10 measurable 
above the lower limits of detection of the assays (IL-6, 14 pg/ml; IL-10, 
<10 pg/ml). Sham, sham operation; PN, parenteral nutrition; EN, 
enteral nutrition; S, starvation; CLP, cecal ligation and puncture.Available online http://ccforum.com/content/11/4/R79
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across the gut [24] and with increased bacterial recovery from
mesenteric lymph nodes [25].
Studies in man, however, are conflicting. In human volunteers
receiving PN versus EN, the administration of endotoxin was
associated with higher temperature, higher C-reactive protein,
higher epinephrine and higher TNFα responses in the PN
group in one study [26] – whereas in another study the
responses to endotoxin were essentially comparable, albeit
with a reduced IL-6 response [27]. Notwithstanding these
changes and their theoretical importance, controlled trials in
man have repeatedly demonstrated an increase in infections in
patients administered PN compared with EN or no nutrition
[4,5], a clinical observation that lends weight to differential
effects of the two routes of feeding on immune function. As
might be expected, 72 hours following CLP or sham operation
we found a wide scatter of serum concentrations of IL-6 and
IL-10. Nonetheless, there appeared to be differences in the
pattern of cytokine concentrations related both to the pres-
ence or absence of sepsis and to the nutritional management
of the animals, with recovery of circulating IL-6 and IL-10 being
more frequent in animals with sepsis administered PN. Fur-
thermore, if these differences are explained by the effect of
absence of EN on the gastrointestinal tract, it is possible that
a more prolonged period of PN, as frequently used in patients,
might have produced a more marked differential in cytokine
recovery between PN and EN animals.
In the clinical management of critically ill patients, balanced
against concerns that use of PN predisposes to deleterious
immunological changes are the risks associated with failure or
delay in provision of nutrition when attempted via the enteral
route. We have found that PN is superior to EN in increasing
hepatic and muscle protein synthesis and circulating levels of
IGF-I [15]. PN also resulted in significantly lower IGFBP-I lev-
els compared with EN in septic animals, despite the greater
recovery of IL-6 and IL-10 in PN-fed animals with sepsis. Our
observations that PN was more efficacious, in comparison
with EN, in influencing circulating IGF-I and IGFBP-I levels are
in contrast to another rodent study comparing PN and EN in
sepsis [28]. In that study, however, nutrition was commenced
48 hours prior to the septic insult, which is not comparable
with the usual situation in patients with sepsis. Furthermore,
the feeds administered were not identical.
In the present study we found increased hepatic mRNA of
IGF-I in association with PN. In addition, hepatic mRNA of the
GHR was increased with both PN and EN. These findings sug-
gest that nutrition is an important stimulant to the synthesis of
GHRs and thus IGF-I. We failed to demonstrate significant dif-
ferences between septic and sham-operated animals in
expression of mRNA of the GHR or IGF-I, nutritional differ-
ences appearing to be of more importance. The effect of sep-
sis on GHRs remains uncertain. After CLP both increased
specific binding of GH to the liver [29] and reduced expres-
sion of hepatic mRNA of GHRs have been demonstrated [14].
Reduced receptor binding and mRNA was found following
endotoxin challenge [30], whilst unchanged GHR mRNA was
demonstrated after fecal agar pellet implantation [13].
Although the pathophysiology of GH resistance in sepsis is
still not fully understood, the current consensus view is that
low circulating concentrations of IGF-I indicate a defect in GH
signal transduction that may occur either at the level of the
GHR or be associated with a change in the intracellular sign-
aling pathway for GH.
The induction of SOCS proteins by hormones and/or
cytokines has been hypothesized to inhibit GH signaling by a
negative feedback loop involving the janus kinase and signal
transducer and activator pathway [12]. Yumet and colleagues
[13] have recently shown in rats with abdominal sepsis that
total GHR numbers are unchanged, with the impaired IGF-I
Figure 2
Results of serum cytokine assays Results of serum cytokine assays. Graphs illustrate serum levels of IL-6 and IL-10, measured 72 hours after sham operation (Sham) or cecal ligation 
and puncture (CLP) in rats with postoperative infusion of saline (Starve), enteral nutrition (EN) or parenteral nutrition (PN). Bars and error bars repre-
sent mean values and standard error of the mean. Significant differences between groups indicated where P < 0.05.Critical Care    Vol 11 No 4    O'Leary et al.
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response to GH being temporally related to a defect in STAT5
activation and increased SOCS mRNA expression. SOCS-1
and CIS expression were increased 4 hours following induc-
tion of sepsis, but by 24 hours were no different from measure-
ments in sham-operated animals – whereas SOCS-3
expression remained elevated at 24 hours. The mechanism of
the increase in SOCS expression in abdominal sepsis is
unknown, and the authors of the study commented that the
time course observed was consistent with that produced by
endotoxin and inflammatory cytokines. Hepatic mRNA of CIS,
SOCS-2 and SOCS-3 is transiently increased following endo-
toxin administration [31], while SOCS-1 expression and
SOCS-3 expression were found to be increased 24 hours fol-
lowing CLP [14]. We now demonstrate continued induction of
SOCS-3 expression at 72 hours after CLP, associated with
reduced hepatic expression of mRNA of IGF-I and reduced
serum IGF-I concentrations. SOCS-3 may be of particular
importance in the mechanism of GH resistance in sepsis.
In light of the previous study that demonstrated an effect of PN
on CIS expression [14], we were particularly interested in the
possibility that nutrition, and possibly the route of feeding,
might influence SOCS expression and thus GH resistance.
We found greater SOCS-3 expression with PN compared
with EN in sepsis, whereas in sham-operated animals the
SOCS-3 expression was lowest in those given PN. In animals
Figure 3
PCR measurements for cytokine-inducible SH2-containing protein, sup- pressors of cytokine signaling-2 and suppressors of cytokine signaling- 3 PCR measurements for cytokine-inducible SH2-containing protein, sup-
pressors of cytokine signaling-2 and suppressors of cytokine signaling-
3. Bars represent the mean expression of mRNA of cytokine-inducible 
SH2-containing protein (CIS), suppressors of cytokine signaling 
(SOCS)-2 and SOCS-3, normalized to 18S rRNA (mean normalized 
expression), measured in the liver from rats 72 hours after laparotomy 
only (Sham) or cecal ligation and puncture (CLP), with postoperative 
saline infusion (Starve), enteral nutrition (EN) or parenteral nutrition 
(PN). Error bars represent standard error of the mean. Significant differ-
ences between groups indicated where P < 0.05.
Figure 4
PCR measurements of insulin-like growth factor-1 and the growth hor- mone receptor PCR measurements of insulin-like growth factor-1 and the growth hor-
mone receptor. Bars represent the mean expression of mRNA of insu-
lin-like growth factor-1 (IGF-I) and growth hormone receptor (GHR), 
normalized to 18S rRNA (mean normalized expression), measured in 
the liver from rats 72 hours after laparotomy only (Sham) or cecal liga-
tion and puncture (CLP), with postoperative saline infusion (Starve), 
enteral nutrition (EN) or parenteral nutrition (PN). Error bars represent 
standard error of the mean. Significant differences between groups 
indicated where P < 0.05.Available online http://ccforum.com/content/11/4/R79
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with sepsis, the CIS expression was increased by EN, and
SOCS-2 expression was greater in sham-operated animals
than septic animals given PN. As seen in the prior study, how-
ever, SOCS-2 expression was not affected by sepsis [14].
These differences in SOCS expression appeared independ-
ent of the induction of mRNA of the GHR or of IGF-I. Our hypo-
thesis is that differential effects of PN versus EN on circulating
levels of cytokines can explain these differences, but it seems
unlikely that these effects are modulated via changes in
number of GHRs. While differences in cytokine levels were
observed, any mechanistic influence of these on SOCS
expression cannot be determined from the present study.
We recognize that there may be problems with interpretation
of the results of the present study. Although we attempted to
limit the size of the ligated area of the cecum and to ensure
bowel continuity was maintained, if generalized peritonitis
occurred after CLP the resultant ileus and intestinal ischemia
may have made nutrition by the enteral route impossible.
Nonetheless, EN is recommended in clinical management
guidelines for a number of conditions where intraabdominal
sepsis may occur, and is said to be tolerated even in the set-
ting of the ileus [32]. The model is therefore clinically relevant
to human abdominal sepsis, in which EN use may be consid-
ered. The model has the advantage over previous studies that
nutrition was commenced after the septic insult was initiated,
as would most probably occur in patients, and that the EN and
PN were identical. Furthermore, the measurements were made
at a single time point 72 hours following operation. Cytokine
levels change in a dynamic way after CLP, with the most pro-
nounced changes occurring transiently well prior to 72 hours.
Our experimental model precluded repeated blood sampling,
but it is our contention that the differences at 72 hours are
more likely to be influenced by the nutritional manipulations
than would changes at earlier time points.
Conclusion
We found that nutrition and the route of nutrition in sepsis dif-
ferentially influence circulating cytokine profiles and the
expression of mRNA of SOCS proteins, of the GHR and of
IGF-I. The present study demonstrates that the choice of nutri-
tion route in sepsis may influence cellular mechanisms that
govern the response to hormones and mediators, which fur-
ther influence the response to nutrients themselves. Although
our results may be heavily influenced by the design of the
experiment and the experimental model, the complex interac-
tions illustrated should be considered in the design of future
trials of nutritional management in patients with sepsis.
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